Mass Spectrometry is key technology for studying critical molecules and pathways. Defining molecular targets is crucial for the process of drug development.
In our group, we are focused on using proteomics, mass spectrometry and biochemical approaches to understand disease processes.
The group has expertise in proteomics based methodologies and hosts a platform containing a variety of chromatography equipment and mass spectrometers.
Kessler Group Sky Garden London Nov 2018
- For Non-Scientists
- Research Overview
- Mass Spectrometry
- Public Engagement
- Photo Gallery
- Virtual tour of the Kessler Lab
- Former Group Members
The Bloom syndrome complex senses RPA-coated single-stranded DNA to restart stalled replication forks
Shorrocks A-MK. et al, (2021), Nature Communications, 12
Phenotypic manifestation of α-synuclein strains derived from Parkinson’s disease and multiple system atrophy in human dopaminergic neurons
Tanudjojo B. et al, (2021), Nature Communications, 12
Inflammasome activation controlled by the interplay between post-translational modifications: emerging drug target opportunities
Liang Z. et al, (2021), Cell Communication and Signaling, 19
Proteomic Signature of Dysfunctional Circulating Endothelial Colony‐Forming Cells of Young Adults
Tan CMJ. et al, (2021), Journal of the American Heart Association
Conformational plasticity of the ULK3 kinase domain.
Mathea S. et al, (2021), The Biochemical journal